| Schedule of changes in the carrying amount of goodwill |
| | | | | | | | | All other | | BIGO | | Total | | | US$ | | US$ | | US$ | | | | | | | | Balance as of December 31, 2023 | | 795,060 | | 1,854,221 | | 2,649,281 | | | | | | | | Impairment (i) | | (454,935) | | — | | (454,935) | Foreign currency translation adjustments | | (22) | | — | | (22) | Balance as of December 31, 2024 | | 340,103 | | 1,854,221 | | 2,194,324 | | | | | | | | Impairment (i) | | — | | — | | — | Foreign currency translation adjustments | | 34 | | — | | 34 | Balance as of December 31, 2025 | | 340,137 | | 1,854,221 | | 2,194,358 |
| (i) | The Group performs its annual goodwill impairment test of each reporting unit in the fourth quarter, or more frequently, if certain events or circumstances warrant. Events or changes in circumstances which might indicate potential impairment in goodwill include the entity-specific factors, including, but not limited to, stock price volatility, market capitalization relative to net book value, and projected revenue, market growth and operating results. The estimated fair value of each reporting unit is determined using either an income approach or a market approach, when appropriate. The quantitative goodwill impairment test compares the fair value of a reporting unit with its carrying amount, including goodwill. If the carrying amount of a reporting unit is greater than zero and its fair value exceeds its carrying amount, goodwill of the reporting unit is considered not to be impaired. Conversely, an impairment is identified and recorded for a reporting unit if the carrying amount exceeds its fair value. |
|